(Q53003995)

10 May 2018

title

Revisiting the specificity of the MHC class II transactivator CIITA in vivo. (English)

1 reference

10 May 2018

Salomé Leibundgut-Landmann

author

Salomé Leibundgut-Landmann

2

0 references

Walter Reith

10

Walter Reith

1 reference

10 May 2018

Hans Acha-Orbea

9

Hans Acha-Orbea

1 reference

10 May 2018

Luc A Otten

1

Luc A Otten

1 reference

10 May 2018

author name string

Joachim Huarte

3

1 reference

10 May 2018

Isabelle C Kos-Braun

4

1 reference

10 May 2018

Christine Lavanchy

5

1 reference

10 May 2018

Emmanuèle Barras

6

1 reference

10 May 2018

Bettina Borisch

7

1 reference

10 May 2018

Viktor Steimle

8

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 June 2006

1 reference

10 May 2018

European Journal of Immunology

published in

1 reference

10 May 2018

volume

36

1 reference

10 May 2018

page(s)

1548-1558

1 reference

10 May 2018

issue

6

1 reference

10 May 2018

Cutting edge: the class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

Cathepsin E: a novel target for regulation by class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

Enhanced production of IL-10 by dendritic cells deficient in CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

Modulation of gene expression by the MHC class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

CIITA expression and Th1-Th2 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

Altered Th1 cell differentiation programming by CIITA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

The bare lymphocyte syndrome and the regulation of MHC expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Genetic control of MHC class II expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Regulation of MHC class II gene expression by the class II transactivator

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Induction of MHC class I expression by the MHC class II transactivator CIITA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

T cell expression of CIITA represses Th1 immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Class II transactivator (CIITA) isoform expression and activity in melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Transcription: tantalizing times for T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Mice lacking the transcription factor CIITA--a second look

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Targeted disruption of the MHC class II Aa gene in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Quantitative control of MHC class II expression by the transactivator CIITA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535687

7 January 2021

Identifiers

DOI

10.1002/EJI.200535687

1 reference

10 May 2018

PubMed ID

16703565

1 reference

10 May 2018